Lilla Nagy

Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1

Tamás Fodor, Magdolna Szántó, Omar Abdul‐Rahman et al. · PLoS ONE · 2016 · 58 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

PARP10 (ARTD10) modulates mitochondrial function

Judit Márton, Tamás Fodor, Lilla Nagy et al. · PLoS ONE · 2018 · 48 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N’-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism

Lilla Nagy, Tibor Docsa, Magdolna Szántó et al. · PLoS ONE · 2013 · 46 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Glycogen phosphorylase inhibition improves beta cell function

Lilla Nagy, Judit Márton, András Vida et al. · British Journal of Pharmacology · 2017 · 45 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels

Magdolna Szántó, Attila Brunyánszki, Judit Márton et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2013 · 42 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +13